Cargando…

Subtype classification for prediction of prognosis of breast cancer from a biomarker panel: correlations and indications

BACKGROUND: Hormone receptors, including the estrogen receptor and progesterone receptor, human epidermal growth factor receptor 2 (HER2), and other biomarkers like Ki67, epidermal growth factor receptor (EGFR, also known as HER1), the androgen receptor, and p53, are key molecules in breast cancer....

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Chuang, Yuan, Jing-Ping, Wei, Wen, Tu, Yi, Yao, Feng, Yang, Xue-Qin, Sun, Jin-Zhong, Sun, Sheng-Rong, Li, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3937188/ https://www.ncbi.nlm.nih.gov/pubmed/24591826 http://dx.doi.org/10.2147/IJN.S58270

Ejemplares similares

Multi-omics analysis identifies osteosarcoma subtypes with distinct prognosis indicating stratified treatment
por: Jiang, Yafei, et al.
Publicado: (2022)

The role of Ki-67 in the proliferation and prognosis of breast cancer molecular classification subtypes
por: Stathopoulos, George P., et al.
Publicado: (2014)

Serum Biomarker Panel for Diagnosis and Prognosis of Pancreatic Ductal Adenocarcinomas
por: Mehta, Shreya, et al.
Publicado: (2021)

Subtype Classification, Immune Infiltration, and Prognosis Analysis of Lung Adenocarcinoma Based on Pyroptosis-Related Genes
por: Liu, Qi, et al.
Publicado: (2022)

Combined detection of dickkopf-1 subtype classification autoantibodies as biomarkers for the diagnosis and prognosis of non-small cell lung cancer
por: Shen, Lei, et al.
Publicado: (2017)

Corrigendum: Serum Biomarker Panel for Diagnosis and Prognosis of Pancreatic Ductal Adenocarcinomas
por: Mehta, Shreya, et al.
Publicado: (2021)

Serum biomarker panel for disease severity and prognosis in patients with COVID‐19
por: Li, Jing, et al.
Publicado: (2023)

Proteomics and metabolomics profiling reveal panels of circulating diagnostic biomarkers and molecular subtypes in stable COPD
por: Zhang, Zili, et al.
Publicado: (2023)

A panel of DNA methylation markers for the classification of consensus molecular subtypes 2 and 3 in patients with colorectal cancer
por: van den Berg, Inge, et al.
Publicado: (2021)

Potential of Immune-Related Genes as Biomarkers for Diagnosis and Subtype Classification of Preeclampsia
por: Wang, Ying, et al.
Publicado: (2020)

Breast Cancer Cell Subtypes Display Different Metabolic Phenotypes That Correlate with Their Clinical Classification
por: Ripoll, Consuelo, et al.
Publicado: (2021)

Metabolic classification of circulating tumor cells as a biomarker for metastasis and prognosis in breast cancer
por: Chen, Jing, et al.
Publicado: (2020)

Identification of HCC Subtypes With Different Prognosis and Metabolic Patterns Based on Mitophagy
por: Wang, Yao, et al.
Publicado: (2021)

Establishment of a 7-gene expression panel to improve the prognosis classification of gastric cancer patients
por: Velásquez Sotomayor, Mariana Belén, et al.
Publicado: (2023)

Biological Diagnosis of Depression: A Biomarker Panel from Several Nonspecial Indicators Instead of the Specific Biomarker(s)
por: Li, Jia-Mei, et al.
Publicado: (2022)

CTHRC1 is a prognosis-related biomarker correlated with immune infiltrates in colon adenocarcinoma
por: Meng, Chuang, et al.
Publicado: (2022)

A DNA Methylation-Based Panel for the Prognosis and Diagnosis of Patients With Breast Cancer and Its Mechanisms
por: Liu, Xiao-Ping, et al.
Publicado: (2020)

DNA Repair Genes Are Associated with Subtype Classification, Prognosis, and Immune Infiltration in Uveal Melanoma
por: Wang, Tao, et al.
Publicado: (2022)

Subtype Classification and Prognosis Signature Construction of Osteosarcoma Based on Cellular Senescence-Related Genes
por: Wang, Hanyu, et al.
Publicado: (2022)

Clusterin is a biomarker of breast cancer prognosis and correlated with immune microenvironment
por: Yang, Ping, et al.
Publicado: (2023)

Diagnostic accuracy of a minimal immunohistochemical panel in at/rt molecular subtyping, correlated to dna-methylation profiling
por: Tauziède-Espariat, Arnault, et al.
Publicado: (2023)

MicroRNA Expression Profile on Solid Subtype of Invasive Lung Adenocarcinoma Reveals a Panel of Four miRNAs to Be Associated with Poor Prognosis in Chinese Patients
por: Zhang, Yong-Qiang, et al.
Publicado: (2016)

Molecular classification of esophagogastric junction carcinoma correlated with prognosis
por: Zou, Long, et al.
Publicado: (2017)

Abnormal Expression of Serum Soluble E-Cadherin is Correlated with Clinicopathological Features and Prognosis of Breast Cancer
por: Liang, Zhi, et al.
Publicado: (2014)

Molecular subtypes and scoring tools related to Foxo signaling pathway for assessing hepatocellular carcinoma prognosis and treatment responsiveness
por: Tu, Sheng, et al.
Publicado: (2023)

CLIC1 and CLIC4 complement CA125 as a diagnostic biomarker panel for all subtypes of epithelial ovarian cancer
por: Singha, Bipradeb, et al.
Publicado: (2018)

Classification of subtypes and identification of dysregulated genes in sepsis
por: Tong, Ran, et al.
Publicado: (2023)

Multiplexed Immunoassay Panel Identifies Novel CSF Biomarkers for Alzheimer's Disease Diagnosis and Prognosis
por: Craig-Schapiro, Rebecca, et al.
Publicado: (2011)

Microfluidics for Profiling miRNA Biomarker Panels in AI-Assisted Cancer Diagnosis and Prognosis
por: Muthamilselvan, Sangeetha, et al.
Publicado: (2023)

Classification of the mitochondrial ribosomal protein-associated molecular subtypes and identified a serological diagnostic biomarker in hepatocellular carcinoma
por: Xie, Cong, et al.
Publicado: (2023)

Radiologic-pathologic correlation in breast cancer: do MRI biomarkers correlate with pathologic features and molecular subtypes?
por: Galati, Francesca, et al.
Publicado: (2022)

tRNA-Derived RNA Fragments Are Novel Biomarkers for Diagnosis, Prognosis, and Tumor Subtypes in Prostate Cancer
por: Liu, Weigang, et al.
Publicado: (2023)

The prognostic value of quantitative analysis of CCL5 and collagen IV in luminal B (HER2−) subtype breast cancer by quantum-dot-based molecular imaging
por: Zhu, Yong-yun, et al.
Publicado: (2018)

Identification and validation of a two-gene expression index for subtype classification and prognosis in Diffuse Large B-Cell Lymphoma
por: Xu, Qinghua, et al.
Publicado: (2015)

Genomic and transcriptomic profiling indicates the prognosis significance of mutational signature for TMB-high subtype in Chinese patients with gastric cancer
por: Cheng, Yanan, et al.
Publicado: (2022)

An Immune Panel Signature Predicts Prognosis of Lung Adenocarcinoma Patients and Correlates With Immune Microenvironment
por: Zhou, Yuan, et al.
Publicado: (2021)

Specific TP53 subtype as biomarker for immune checkpoint inhibitors in lung adenocarcinoma
por: Sun, Hao, et al.
Publicado: (2020)

HDNA methylation data-based molecular subtype classification related to the prognosis of patients with hepatocellular carcinoma
por: He, Hui, et al.
Publicado: (2020)

A Panel of Overexpressed Proteins for Prognosis in Esophageal Squamous Cell Carcinoma
por: Shang, Li, et al.
Publicado: (2014)

Correlation of survival and EGFR mutation with predominant histologic subtype according to the new lung adenocarcinoma classification in stage IB patients
por: Sun, Yan, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_oujirm21190eno1b6i16ej4tu6